Spectrum Pharma (SPPI) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts SPPI Hot Sheet
Join SI Premium – FREE
Spectrum Pharma (NASDAQ: SPPI) reported Q2 EPS of ($0.26), $0.01 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $34.3 million versus the consensus estimate of $30.5 million.
For earnings history and earnings-related data on Spectrum Pharma (SPPI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c
- Femasys Inc. (FEMY) Misses Q2 EPS by 20c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
